Hyperlipidemia, also called high cholesterol, affects millions of people worldwide and increases the risk of serious cardiovascular problems like heart attacks and strokes. Managing this condition involves a combination of dietary changes, physical activity, and sometimes medication — all designed to reduce harmful cholesterol levels and protect your heart health for the long term.

Understanding Treatment Goals for Hyperlipidemia

When doctors talk about treating hyperlipidemia, they focus on managing the levels of fats, known as lipids, in your blood. The main goal is to lower what is called “bad cholesterol” or LDL cholesterol, which can build up inside your arteries and create blockages. At the same time, treatment aims to maintain or increase “good cholesterol,” known as HDL cholesterol, which helps clear cholesterol from your bloodstream. Another target is reducing triglycerides, a type of fat that also contributes to artery-clogging plaque.^[1]

The approach to treating hyperlipidemia depends on several factors unique to each person. Your doctor will consider your age, overall health, family history, whether you smoke, if you have diabetes or high blood pressure, and whether you have already experienced a heart attack or stroke. These factors help determine your risk level and guide decisions about treatment intensity. For some people, lifestyle changes alone may be enough. For others, medications are needed right away to bring cholesterol levels down quickly and reduce the risk of cardiovascular events.^[3]

Medical societies and organizations worldwide have developed guidelines to help doctors treat hyperlipidemia effectively. These guidelines are based on years of research showing that lowering LDL cholesterol reduces the chance of heart disease, heart attacks, and strokes. Treatment is personalized, meaning your doctor sets cholesterol targets based on your individual risk profile. Managing hyperlipidemia is not a short-term effort. It requires long-term commitment to healthy habits and, for many people, continuing medication to keep cholesterol levels in check over time.^[4]

Beyond the medications prescribed by doctors, researchers continue to explore new therapies in clinical trials. These studies test innovative drugs and treatment strategies that may offer better results or fewer side effects than current options. While standard treatments are well established and proven effective, clinical research keeps pushing forward to find even better ways to protect people from the dangers of high cholesterol.

Standard Treatment Approaches for Hyperlipidemia

The foundation of hyperlipidemia treatment is what doctors call “therapeutic lifestyle changes.” This means adjusting your diet, increasing physical activity, maintaining a healthy weight, quitting smoking, and limiting alcohol. These changes are recommended for everyone with high cholesterol, regardless of whether they also take medication. Research consistently shows that lifestyle modifications can lower LDL cholesterol by meaningful amounts and reduce cardiovascular risk.^[4]

Dietary changes play a central role. Doctors advise eating less saturated fat, which is found in red meat, full-fat dairy products, butter, and many fried and processed foods. Trans fats, which appear in some margarines and commercially baked goods, should be avoided entirely because they raise LDL cholesterol and lower HDL cholesterol. Instead, people with hyperlipidemia are encouraged to eat foods rich in unsaturated fats, such as olive oil, nuts, avocados, and fatty fish like salmon and mackerel. These healthier fats can actually improve cholesterol levels.^[9]

Increasing soluble fiber intake is another effective dietary strategy. Soluble fiber, found in oatmeal, beans, lentils, apples, and barley, helps reduce the absorption of cholesterol into the bloodstream. Adding plant stanols and sterols — compounds found in certain fortified foods like spreads and juices — can also block cholesterol absorption. Including more vegetables, fruits, and whole grains in your daily meals provides vitamins, minerals, and fiber that support heart health.^[9]

Physical activity is equally important. Regular exercise helps lower LDL cholesterol and triglycerides while raising HDL cholesterol. The American Heart Association recommends at least 150 minutes of moderate-intensity aerobic exercise each week, such as brisk walking, cycling, or swimming. Even 30 minutes most days of the week can make a difference. Exercise also helps with weight management, blood pressure control, and overall cardiovascular fitness.^[9]

When lifestyle changes alone are not enough to reach cholesterol targets, doctors prescribe medications. The most commonly used and well-studied medications are called statins. Statins work by blocking an enzyme in the liver that produces cholesterol, which lowers the amount of LDL cholesterol in the blood. Examples of statins include simvastatin, atorvastatin, rosuvastatin, and pravastatin. Clinical trials have shown that statins significantly reduce the risk of heart attacks, strokes, and death from cardiovascular disease.^[11]

Statins are generally taken once daily, often in the evening, because the liver produces most cholesterol at night. They are usually well tolerated, but some people experience side effects such as muscle aches, digestive problems, or, rarely, liver enzyme changes. Doctors monitor patients on statins with regular blood tests to check cholesterol levels and liver function. Despite concerns about side effects, statins remain the cornerstone of cholesterol-lowering therapy because their benefits far outweigh the risks for most people.^[11]

If statins alone do not lower cholesterol enough, or if a person cannot tolerate statins, doctors may add or substitute other medications. Ezetimibe is a drug that blocks cholesterol absorption in the intestines, reducing LDL cholesterol levels. It is often combined with a statin to achieve greater reductions. Another option is bile acid sequestrants, also called resins, which bind to bile acids in the intestines and prevent cholesterol from being reabsorbed. These drugs can cause digestive side effects like bloating and constipation.^[16]

Fibrates are medications primarily used to lower triglycerides and raise HDL cholesterol. They are less effective at reducing LDL cholesterol but can be helpful for people with very high triglyceride levels. Fibrates include gemfibrozil and fenofibrate. Niacin, a form of vitamin B3, also raises HDL cholesterol and lowers LDL cholesterol and triglycerides. However, niacin can cause flushing, itching, and other side effects, and its use has declined because clinical trials did not show significant reductions in cardiovascular events when added to statins.^[13]

For people at very high risk or with extremely high cholesterol levels, doctors may prescribe newer injectable medications called PCSK9 inhibitors. These drugs, including alirocumab, evolocumab, and inclisiran, work by helping the liver remove more LDL cholesterol from the blood. They are very effective at lowering LDL cholesterol, sometimes by more than 50 percent. PCSK9 inhibitors are typically reserved for patients who have not reached their cholesterol goals with statins and other drugs, or for those with genetic conditions causing very high cholesterol.^[16]

Bempedoic acid is another medication approved for lowering LDL cholesterol. It works similarly to statins but in a different part of the cholesterol production pathway, which may make it better tolerated by people who experience muscle pain with statins. Bempedoic acid is taken as a daily pill and is often used in combination with other cholesterol-lowering drugs.^[16]

The duration of cholesterol-lowering treatment is typically lifelong. Hyperlipidemia is a chronic condition, and stopping medication usually causes cholesterol levels to rise again. Doctors emphasize that treatment is a long-term commitment. Regular follow-up visits and blood tests help ensure that cholesterol levels remain at target and that medications are working without causing harmful side effects.^[1]

Treatment in Clinical Trials: Exploring New Therapies

While standard treatments for hyperlipidemia are effective, researchers are constantly working to develop new and improved therapies. Clinical trials are research studies that test promising drugs and treatment approaches in human volunteers. These trials are essential for bringing innovative therapies from the laboratory to patients. Participating in a clinical trial may give patients access to cutting-edge treatments before they become widely available, though there are also risks and uncertainties involved.

Clinical trials for hyperlipidemia typically focus on finding new ways to lower LDL cholesterol, raise HDL cholesterol, reduce triglycerides, or improve cardiovascular outcomes. Trials are conducted in phases. Phase I trials test a new drug’s safety and determine the best dose in a small group of healthy volunteers or patients. Phase II trials involve more participants and assess whether the drug works as intended and continues to be safe. Phase III trials are large studies that compare the new treatment to the current standard of care to confirm its effectiveness, monitor side effects, and collect information that allows the drug to be used safely. If a drug performs well in Phase III, it may be submitted to regulatory agencies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for approval.^[14]

One area of active research involves developing new drugs that target different pathways involved in cholesterol metabolism. For example, scientists are studying medications that inhibit a protein called angiopoietin-like protein 3 (ANGPTL3). Blocking this protein can lower LDL cholesterol, triglycerides, and other harmful lipids. Early trials of ANGPTL3 inhibitors have shown promising results in reducing cholesterol levels, and larger studies are underway to determine whether they reduce cardiovascular events.

Another innovative approach being tested in clinical trials is RNA interference (RNAi) therapy. This treatment uses small pieces of genetic material to silence genes involved in cholesterol production. Inclisiran, a PCSK9 inhibitor that uses RNAi technology, has already been approved in some countries based on successful trial results. Researchers are exploring similar RNAi strategies to target other genes that regulate cholesterol and lipid levels. The advantage of RNAi therapies is that they may require less frequent dosing — sometimes only two or three times per year — compared to daily pills or monthly injections.

Clinical trials are also investigating new oral medications that offer alternatives to statins. Some of these drugs work by blocking different enzymes in the cholesterol synthesis pathway or by enhancing the liver’s ability to clear LDL cholesterol from the blood. Researchers are particularly interested in developing medications that are effective but cause fewer muscle-related side effects, which are the most common reason people stop taking statins.

Combination therapies are another focus of clinical research. Studies are testing whether combining multiple cholesterol-lowering drugs with different mechanisms of action can achieve greater reductions in LDL cholesterol and better cardiovascular outcomes than single-drug therapy. For example, trials are examining combinations of statins with ezetimibe, bempedoic acid, or PCSK9 inhibitors to see if these regimens provide additional benefits.

Some clinical trials are exploring the role of gene therapy for treating hyperlipidemia, particularly in patients with inherited forms of the condition such as familial hypercholesterolemia. Gene therapy involves introducing or modifying genes to correct the underlying genetic defect that causes high cholesterol. While still in early stages, this approach holds the potential for long-lasting or even permanent treatment.

Researchers are also studying the cardiovascular effects of existing drugs in new ways. For example, clinical trials are evaluating whether medications that lower triglycerides — such as high-dose omega-3 fatty acids or fibrates — can reduce heart attacks and strokes in people who already have well-controlled LDL cholesterol. Some of these trials have shown mixed results, prompting further investigation into which patients might benefit most from triglyceride-lowering therapy.

Clinical trials for hyperlipidemia are conducted at medical centers and research institutions around the world, including in the United States, Europe, and Asia. Eligibility criteria vary depending on the trial but often include factors such as age, cholesterol levels, cardiovascular risk, and whether the person is already taking other medications. Patients interested in participating in a clinical trial should discuss the option with their doctor, who can help determine if a trial is appropriate and safe.

While clinical trials offer the possibility of accessing innovative treatments, they also come with uncertainties. New drugs may not work as well as expected, or they may cause unexpected side effects. Participants in clinical trials are closely monitored by medical teams, and their safety is a top priority. However, it is important for patients to understand the potential risks and benefits before enrolling in a trial.

Most common treatment methods

• Lifestyle Changes
  • Reducing intake of saturated and trans fats found in red meat, full-fat dairy, and fried foods
  • Increasing consumption of unsaturated fats from olive oil, nuts, avocados, and fatty fish
  • Adding soluble fiber from oatmeal, beans, fruits, and whole grains
  • Fortifying diet with plant stanols and sterols in certain spreads and juices
  • Performing at least 150 minutes of moderate aerobic exercise per week
  • Maintaining a healthy weight through diet and physical activity
  • Quitting smoking and limiting alcohol to one or two drinks per day
• Statin Medications
  • Most commonly prescribed cholesterol-lowering drugs that block liver enzyme producing cholesterol
  • Examples include simvastatin, atorvastatin, rosuvastatin, and pravastatin
  • Significantly reduce LDL cholesterol and cardiovascular events
  • Taken once daily, usually in the evening
  • Possible side effects include muscle aches, digestive problems, or liver enzyme changes
• Ezetimibe
  • Blocks cholesterol absorption in the intestines
  • Often combined with statins for greater LDL cholesterol reduction
• PCSK9 Inhibitors
  • Injectable medications including alirocumab, evolocumab, and inclisiran
  • Help liver remove more LDL cholesterol from blood
  • Can lower LDL cholesterol by more than 50 percent
  • Reserved for high-risk patients or those not reaching goals with statins
• Bempedoic Acid
  • Oral medication that lowers LDL cholesterol through a different pathway than statins
  • May be better tolerated by people who experience muscle pain with statins
  • Often used in combination with other cholesterol-lowering drugs
• Fibrates
  • Primarily used to lower triglycerides and raise HDL cholesterol
  • Examples include gemfibrozil and fenofibrate
  • Helpful for people with very high triglyceride levels
• Bile Acid Sequestrants
  • Bind to bile acids in intestines and prevent cholesterol reabsorption
  • Can cause digestive side effects like bloating and constipation
• Niacin
  • Form of vitamin B3 that raises HDL and lowers LDL cholesterol and triglycerides
  • Can cause flushing, itching, and other side effects
  • Use has declined due to mixed results in clinical trials